Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Robert Grant

Plastic and Reconstructive Surgery New York, NY Medical Doctor

NPI 1619996360 CMS profile 254573

161 Fort Washington Ave Fl 5, New York, NY 10032

Open in the dashboard

General payments

$207,308

212 records reported · program years 2019–2025

Research payments

$3,375

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Robert Grant of New York, NY is reported in the CMS Open Payments database as having received $207,308 across 212 general payments and $3,375 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,329 3
2024 General $23,744 16
2023 General $17,656 25
2022 General $27,162 19
2022 Research $3,375 1
2021 General $42,227 47
2020 General $21,250 38
2019 General $71,940 64

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Robert Grant
  • Plastic and Reconstructive Surgery median
  • Middle half of Plastic and Reconstructive Surgery
  • National median

In program year 2025, general payments to Robert Grant were reported at $3,329. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.

Show as a table
Year Robert Grant Plastic and Reconstructive Surgery median Middle half National median
2019 $71,940 $335 $121–$1,264 $163
2020 $21,250 $162 $57–$417 $114
2021 $42,227 $245 $89–$735 $132
2022 $27,162 $325 $120–$932 $149
2023 $17,656 $343 $129–$999 $160
2024 $23,744 $390 $141–$1,085 $164
2025 $3,329 $442 $150–$1,242 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Allergan Inc. $68,926 66 payments
  2. KCI USA, Inc $37,688 29 payments
  3. Davol Inc. $37,157 27 payments
  4. Integra LifeSciences Corporation $31,771 35 payments
  5. AbbVie, Inc. $27,618 32 payments
  6. Smith+Nephew, Inc. $1,210 1 payment
  7. Becton, Dickinson and Company $1,106 5 payments
  8. C. R. Bard, Inc. & Subsidiaries $387 2 payments
  9. Acell, Inc. $370 3 payments
  10. W. L. Gore & Associates, Inc. $141 1 payment
  11. Other $933 11 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $149,747 51 payments
  2. Travel and Lodging $37,707 65 payments
  3. Honoraria $8,875 4 payments
  4. Food and Beverage $8,269 90 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,710 2 payments
Products named General payments · program years 2019–2025
  1. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastics $26,594 22 payments
  2. ALLODERM $25,246 11 payments
  3. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastic Surgery $25,218 31 payments
  4. PREVENA $23,359 11 payments
  5. NATRELLE $17,214 38 payments
  6. INTEGRA WOUND MATRIX (THIN) $16,716 14 payments
  7. INTEGRA MESHED BILAYER WOUND MATRIX $16,716 14 payments
  8. SURGIMEND $14,875 4 payments
  9. REVOLVE $14,817 20 payments
  10. Cavilon No Sting Barrier Film $11,310 2 payments
  11. Other $87,903 121 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Allergan Inc. $3,375 1 payment

Records

213 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic and Reconstructive Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record